Showing results (191-200 of 275) with videos related to

Sort By:
Pageof 28
Cancer Medicine|January 25, 2019
Improved survival outcomes and restoration of graft-vs-leukemia effect by deferasirox after allogeneic stem cell transplantation in acute myeloid leukemiaByung-Sik Cho, Young-Woo Jeon, A-Reum Hahn, et al.
Annals of Hematology|January 16, 2013
The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective studySeung-Hwan Shin, Jae-Ho Yoon, Seung-Ah Yahng, et al.
European Journal of Haematology|May 15, 2018
Comparison of transplant-specific prognostic scoring systems in haploidentical transplantation for myelodysplastic syndromeSeung-Hwan Shin, Young-Woo Jeon, Jae-Ho Yoon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 21, 2012
Graft-versus-tumor effect according to type of graft-versus-host disease defined by National Institutes of Health consensus criteria and associated outcomesByung-Sik Cho, Sung-Eun Lee, Hae-Hiang Song, et al.
Journal of Hematology & Oncology|January 25, 2017
High WT1 expression is an early predictor for relapse in patients with acute promyelocytic leukemia in first remission with negative PML-RARa after anthracycline-based chemotherapy: a single-center cohort studyJae-Ho Yoon, Hee-Je Kim, Dae-Hun Kwak, et al.
Cancers|March 29, 2023
A Successful Bridge Therapy Combining Hypomethylating Agents with Venetoclax for Adult Patients with Newly Diagnosed or Relapsed/Refractory Acute Myeloid LeukemiaSu-Yeon Bang, Silvia Park, Daehun Kwag, et al.
European Journal of Haematology|October 11, 2022
Cytogenetic and molecular characteristics and outcomes of adult patients with early T-cell precursor acute lymphoblastic leukemiaJae-Ho Yoon, Hoon Seok Kim, Gi June Min, et al.
Annals of Hematology|January 13, 2016
Prognostic factors for re-mobilization using plerixafor and granulocyte colony-stimulating factor (G-CSF) in patients with malignant lymphoma or multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy: the Korean multicenter retrospective studyJin Seok Kim, Dok Hyun Yoon, Seonyang Park, et al.
European Journal of Haematology|October 6, 2007
Gemtuzumab ozogamicin in combination with attenuated doses of standard induction chemotherapy can successfully induce complete remission without increasing toxicity in patients with acute myeloid leukemia aged 55 or olderKi-Seong Eom, Hee-Je Kim, Woo-Sung Min, et al.
Annals of Hematology|June 26, 2018
Low frequency of CD3<sup>+</sup>CD4<sup>+</sup>CD161<sup>+</sup> T cells correlates with the occurrence of infections in refractory/relapsed multiple myeloma patients receiving lenalidomide plus low-dose dexamethasone treatmentSung-Eun Lee, Ji-Young Lim, Da-Bin Ryu, et al.
Pageof 28